Zenvision Pharma Llp Profile
Key Indicators
- Obligation of Contribution ₹ 1.14 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 34.88 Cr
About Zenvision Pharma Llp
Zenvision Pharma Llp (ZPL) is 9 Year, 7 Months old Limited Liability Partnership 19 June 2015. Its registered office is in Raigarh, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 1.14 M as per MCA.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN/FCRN
AAE-2082
- Incorporation Date
19 Jun 2015
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Zenvision Pharma Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Pophale  | Designated Partner | 19-Jun-2015 | Current |
| Bobba Sivakumar | Designated Partner | 19-Jun-2015 | Current |
Financial Performance of Zenvision Pharma Llp.
Enhance accessibility to Zenvision Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Zenvision Pharma Llp?
Unlock access to Zenvision Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vadivarhe Speciality Chemicals LimitedSunil Pophale is a mutual person
Reelabs Private LimitedSunil Pophale is a mutual person
Pophale International LlpSunil Pophale is a mutual person
- Respect Labs Llp
Bobba Sivakumar is a mutual person
- Novo Pharmsol Llp
Bobba Sivakumar is a mutual person
- Zenres Labs Private Limited
Bobba Sivakumar is a mutual person
Charges (Loans)
₹348.80 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 31.00 Cr
- Canara Bank : 1.98 Cr
- Profectus Capital Private Limited : 1.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Nov 2022 | Bank Of India | ₹31.00 Cr | Open |
| 31 May 2022 | Profectus Capital Private Limited | ₹1.90 Cr | Open |
| 27 Sep 2021 | Canara Bank | ₹1.98 Cr | Open |
How Many Employees Work at Zenvision Pharma Llp?
Zenvision Pharma Llp has a workforce of 98 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenvision Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenvision Pharma Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.